Society for Endocrinology - a world-leading authority on hormones

Corporate Supporters

Ipsen Ltd
190 Bath Road
Slough SL1 3XE
UK

Tel: 01753-627777
Fax: 01753-627778

www.ipsen.co.uk

Ipsen is a global specialty driven pharmaceutical company with a significant presence in consumer healthcare. Ipsen sells more than 20 drugs in over 115 countries, with a direct commercial presence in over 30 countries worldwide. The Group has more than 4,900 employees all over the world.

Ipsen is a global specialty driven pharmaceutical company with a significant presence in consumer healthcare. Ipsen sells more than 20 drugs in over 115 countries, with a direct commercial presence in over 30 countries worldwide. The Group has more than 4,900 employees all over the world.

Ipsen’s ambition is to become a leader in specialty healthcare solutions for targeted debilitating diseases. Its field of expertise covers oncology, neurosciences and endocrinology (adult & paediatric).

Ipsen’s commitment to oncology is exemplified through its growing portfolio of key therapies improving the care of patients suffering neuro-endocrine tumours, prostate cancer, bladder cancer and renal cancer. Ipsen also has a significant presence in primary care.

The Ipsen Group has an active policy of partnerships. Ipsen’s R&D is focused on its innovative and differentiated technological platforms, peptides and toxins, located in the heart of the leading biotechnological and life sciences hubs.

Partnership level

Platinum members

Gold members

Silver members